Physician

Bibas Reddy, D.O.

According to 2025 Medicare claims, Bibas Reddy, D.O. (NPI: 1457577017) practices medical oncology in the Fort Worth-Arlington-Grapevine, TX market, with the plurality of this provider's patient population coming from Tarrant, TX. This provider's primary affiliated billing organization is ONCOLOGY-HEMATOLOGY CONSULTANTS PA (NPI: 1629021159; TIN: 752512142) and primary practice location at 76104-4611. Reddy is affiliated with the UT Southwestern Accountable Care Network (ACO ID: D0211), participating under the REACH model.

Reddy's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 430 traditional Medicare patients, billed 130,827 HCPCS/CPT codes, and received $2,418,194 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 514 prescription claims across 134 beneficiaries totaling $800,249 in drug costs, led by Ibrance (Palbociclib). DME data shows 100 claims. Open Payments data shows 58 records totaling $1,853. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	586	220,038	$1,283,320
2016	622	211,532	$1,584,888
2017	731	238,575	$1,938,555
2018	651	150,937	$2,072,637
2019	601	196,244	$2,283,241
2020	447	185,106	$2,681,744
2021	484	125,462	$2,169,191
2022	455	114,480	$1,950,207
2023	411	122,329	$1,821,358
2024	430	130,827	$2,418,194

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	138	941	$992,600
2016	139	841	$809,792
2017	148	800	$1,191,517
2018	163	734	$1,429,200
2019	153	877	$2,447,661
2020	144	758	$1,679,787
2021	146	679	$1,568,184
2022	134	578	$1,302,043
2023	126	524	$1,217,870
2024	134	514	$800,249

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	158	$18,027
2016	N/R	104	$17,137
2017	N/R	13	$6,930
2018	N/R	38	$5,821
2019	N/R	45	$4,486
2020	N/R	70	$120,989
2021	N/R	16	$1,806
2022	N/R	58	$1,860
2023	N/R	26	$4,731
2024	N/R	100	$6,075

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	134	328	$133
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	213	548	$94
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	147	223	$65
71260	Ct scan of chest with contrast	104	180	$56
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	76	92	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	15	420	$216,337
Eliquis	Apixaban	20	960	$19,270
Xarelto	Rivaroxaban	13	425	$7,833
Prochlorperazine Maleate	Prochlorperazine Maleate	55	471	$619
Ondansetron Odt	Ondansetron	46	493	$550

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	11	$2,386
B4034	Enteral feeding supply kit; syringe fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape	N	N/R	14	$1,348
J8700	Temozolomide, oral, 5 mg	N	N/R	18	$1,099
J8521	Capecitabine, oral, 500 mg	N	N/R	17	$602
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	22	$414

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	58	$1,853	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bibas Reddy, D.O.?

Tedicare shows public-source Medicare data for Bibas Reddy, D.O. (NPI 1457577017), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bibas Reddy, D.O. have ACO affiliation data?

Bibas Reddy, D.O. is shown with ACO affiliation data for UT Southwestern Accountable Care Network (REACH, ACO ID D0211).

What billing organization is linked to Bibas Reddy, D.O.?

Bibas Reddy, D.O. is linked to ONCOLOGY-HEMATOLOGY CONSULTANTS PA (billing NPI 1629021159) in the available physician profile data.

Does Bibas Reddy, D.O. have Open Payments data?

Bibas Reddy, D.O. has 58 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.